BTIG Research Raises Adaptive Biotechnologies (NASDAQ:ADPT) Price Target to $8.00
Adaptive Biotechnologies (NASDAQ:ADPT – Free Report) had its price objective increased by BTIG Research from $7.00 to $8.00 in a research report report published on Wednesday morning, Benzinga reports. BTIG Research currently has a buy rating on the stock. Separately, JPMorgan Chase & Co. upped their price target on shares of Adaptive Biotechnologies from $5.00 […]
5 Oct 02:25 · The Cerbat Gem